Akcea Therapeutics: 3Q Earnings Snapshot

November 5, 2019 GMT

BOSTON (AP) _ Akcea Therapeutics Inc. (AKCA) on Tuesday reported a loss of $31.5 million in its third quarter.

The Boston-based company said it had a loss of 34 cents per share.

The biopharmaceutical company posted revenue of $20.6 million in the period.

Akcea Therapeutics shares have fallen 40% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $18.23, a drop of 32% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AKCA at https://www.zacks.com/ap/AKCA